Novel therapeutic targets in non-small cell lung cancer
Author:
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference62 articles.
1. Global cancer statistics;Jemal;CA Cancer J Clin,2011
2. Histological Typing of Lung and Pleural Tumours;Travis,1999
3. A novel classification of lung cancer into molecular subtypes;West;PLoS ONE,2012
4. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib;Lynch;N Engl J Med,2004
5. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy;Paez;Science,2004
Cited by 72 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Meta-analysis of Targeted Therapies in EGFR-mutated Non–Small Cell Lung Cancer;American Journal of Clinical Oncology;2024-09-11
2. Targeting hyaluronan metabolism-related molecules associated with resistant tumor-initiating cells potentiates chemotherapy efficacy in lung cancer;Scientific Reports;2024-07-22
3. Utility of molecular markers in predicting local control specific to lung cancer spine metastases treated with stereotactic body radiotherapy;Journal of Neuro-Oncology;2024-03-25
4. Utility of Molecular Markers in Predicting Local Control Specific to Lung Cancer Spine Metastases Treated with Stereotactic Body Radiotherapy;2024-01-09
5. A Comprehensive Overview of Various Cancer Types and Their Progression;Handbook of Oncobiology: From Basic to Clinical Sciences;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3